Reteplase contraindications: Difference between revisions

Latest revision as of 17:04, 20 August 2015

Redirect to:

@@ Line 1: / Line 1: @@
-__NOTOC__
+#REDIRECT [[Reteplase#Contraindications]]
-{{Reteplase}}
-{{CMG}}; {{AE}} {{AZ}}
-==Contraindications==
+[[Category: Cardiovascular Drugs]]
+[[Category: Drug]]
-Because thrombolytic therapy increases the risk of bleeding, Retavase® is contraindicated in the following situations<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = RETAVASE (RETEPLASE) KIT [EKR THERAPEUTICS, INC.] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e9ae6656-977c-4105-8528-bee664aab27a | publisher =  | date =  |accessdate =  }}</ref>:
+[[Category: Anticoagulants]]
-:*Active internal [[bleeding]]
-:*History of [[cerebrovascular accident]]
-:*Recent intracranial or intraspinal surgery or trauma (see WARNINGS)
-:*Intracranial neoplasm, [[arteriovenous malformation]], or [[aneurysm]]
-:*Known bleeding diathesis
-:*Severe uncontrolled [[hypertension]]
-==References==
-{{Reflist}}
-{{FDA}}
-[[Category:Drugs]]